•Table Set 4: Hb (g/dL) Adjusted Percent Change From Baseline Longitudinal Repeated Measures Analysis, 24-Week Double-blind Treatment Period in Patients With eGFR <60 mL/min/1.73 m2, by Anemia Subgroup. The gene discussed is GSTM1; the disease is anemia (phenotype).